Back to results
US 2025/0144079 A1Published application
Methods of inhibiting tumor metastasis
AssigneeVanderbilt University
InventorsJill M. Pulley, Robert R. Lavieri
Life of this patent
Estimating the term…
Abstract
Thromboxane A2 receptor antagonists, such as ifetroban, inhibit solid tumor metastasis. The formation of surface and microscopic lung metastases are inhibited. Thromboxane A2 receptor antagonists can inhibit the tumor metastasis process without affecting the growth or development of a primary tumor.
Claims19
A method of inhibiting solid tumor metastasis comprising administering to a subject in need thereof, an amount of a thromboxane A2 receptor antagonist, or a pharmaceutically acceptable salt or composition thereof, effective to inhibit metastasis of a solid tumor in the subject.
19-21. (canceled)
Dependencies are inferred from the claim text.